Viewing Study NCT01288469


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-01 @ 8:24 AM
Study NCT ID: NCT01288469
Status: COMPLETED
Last Update Posted: 2015-09-24
First Post: 2011-02-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DFI11566
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View